Growth hormone treatment does not affect incidences of middle ear disease or hearing loss in infants and toddlers with turner syndrome

Hormone Research in Paediatrics

Volumn 74, Issue 1, 2010, Pages 23-32

  Davenport, Marsha L ^a   Roush, Jackson ^a   Liu, Chunhua ^b   Zagar, Anthony J ^b   Eugster, Erica ^c,d   Travers, Sharon ^e   Fechner, Patricia Y ^f   Quigley, Charmian A ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b Lilly USA   (United States)

^c RILEY HOSPITAL FOR CHILDREN   (United States)

^d INDIANA UNIVERSITY   (United States)

^e CHILDREN S HOSPITAL   (United States)

^f SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

Conductive hearing loss; Otitis media child; Preschool; Sensorineural hearing loss; Somatropin; Turner syndrome; Tympanostomy tube

Indexed keywords

ANTIBIOTIC AGENT; HUMAN GROWTH HORMONE;

ANTIBIOTIC THERAPY; ARTICLE; AUDIOLOGY; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; EAR SURGERY; FEMALE; HEARING DISORDER; HEARING LOSS; HORMONAL THERAPY; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MIDDLE EAR DISEASE; MORBIDITY; MULTICENTER STUDY; OTITIS MEDIA; OUTCOME ASSESSMENT; PATIENT MONITORING; PERCEPTION DEAFNESS; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; TODDLER; TURNER SYNDROME; TYMPANOMETRY; TYMPANOSTOMY TUBE;

AUDIOLOGY; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HEARING LOSS; HUMAN GROWTH HORMONE; HUMANS; INFANT; INSULIN-LIKE GROWTH FACTOR I; LONGITUDINAL STUDIES; OTITIS MEDIA; OTOSCOPY; PROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS; TURNER SYNDROME;

EID: 77954765896     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000313964     Document Type: Article

References (40)

1. Nielsen J, Wohlert M: Chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Aarhus, Denmark. Hum Genet 1991;87: 81-83.
2. Davenport ML, Calikoglu AS: Turner Syndrome; in Pescovitz OH, Eugster EA (eds): Pediatric Endocrinology. Mechanisms, Manifestations, and Management. Philadelphia, Lippincott Williams & Wilkins, 2004, pp 203-223.
3. Bondy CA: Care of girls and women with Turner syndrome: a guideline of the Turner syndrome study group. J Clin Endocrinol Metab 2007;92:10-25.
4. Carel JC, Ecosse E, Bastie-Sigeac I, Cabrol S, Tauber M, Leger J, Nicolino M, Brauner R, Chaussain JL, Coste J: Quality of life determinants in young women with Turner's syndrome after growth hormone treatment: results of the StaTur population-based cohort study. J Clin Endocrinol Metab 2005; 90: 1992-1997.
5. Güngör N, Böke B, Belgin E, Tunçbilek E: High frequency hearing loss in Ullrich- Turner syndrome. Eur J Pediatr 2000; 159: 740-744.
6. Hultcrantz M: Ear and hearing problems in Turner's syndrome. Acta Otolaryngol 2003; 123:253-257.
7. Dhooge IJ, De Vel E, Verhoye C, Lemmerling M, Vinck B: Otologic disease in Turner syndrome. Otol Neurotol 2005;26:145-150.
8. King KA, Makishima T, Zalewski CK, Bakalov VK, Griffith AJ, Bondy CA, Brewer CC: Analysis of auditory phenotype and karyotype in 200 females with Turner syndrome. Ear Hear 2007;28:831-841.
9. Parkin M, Walker P: Hearing loss in Turner syndrome. Int J Pediatr Otorhinolaryngol 2009;73: 243-247.
10. Beckman A, Conway GS, Cadge B: Audio - logical features of Turner's syndrome in adults. Int J Audiol 2004;43:533-544.
11. Rosenfeld RM, Culpepper L, Doyle KJ, Grundfast KM, Hoberman A, Kenna MA, Lieberthal AS, Mahoney M, Wahl RA, Woods CR Jr, Yawn B, American Academy of Pediatrics Subcommittee on Otitis Media with Effusion, American Academy of Family Physicians, American Academy of Otolaryngology-Head and Neck Surgery: Clinical practice guideline: otitis media with effusion. Otolaryngol Head Neck Surg 2004; 130: S95-S118.
12. Quigley CA, Crowe BJ, Anglin DG, Chipman JJ, US Turner Syndrome Study Group: Growth hormone and low-dose estrogen in Turner syndrome: results of a United States multi-center trial to near-final height. J Clin Endocrinol Metab 2002;87:2033-2041.
13. Stephure DK, Canadian Growth Hormone Advisory Committee: Impact of growth hormone supplementation on adult height in Turner syndrome: results of the Canadian randomized controlled trial. J Clin Endocrinol Metab 2005;90:3360-3366.
14. Wernicke JF, Faries D, Milton D, Weyrauch K: Detecting treatment-emergent adverse events in clinical trials: a comparison of spontaneously reported and solicited collection methods. Drug Saf 2005;28:1057-1063.
15. Davenport ML, Crowe BJ, Travers SH, Rubin K, Ross JL, Fechner PY, Gunther DF, Liu C, Geffner ME, Thrailkill K, Huseman C, Zagar A, Quigley CA: Growth hormone treatment of early growth failure in toddlers with Turner syndrome: a randomized, controlled, multicenter trial. J Clin Endocrinol Metab 2007;92:3406-3416.
16. Zill N: Parental schooling and children's health. Public Health Rep 1996;111:34-43.
17. Rovers MM, Schilder AG, Zielhuis GA, Rosenfeld RM: Otitis media. Lancet 2004; 363: 465-473.
18. Margolis RH, Hunter LL: Acoustic immittance measurements; in Roeser RJ, Valente M, Hosford-Dunn H (eds): Audiology. Diagnosis. New York, Thieme Medical Publishers, 2000, pp 381-425.
19. Nozza RJ, Bluestone CD, Kardatzke D, Bachman R: Towards the validation of aural acoustic immittance measures for diagnosis of middle ear effusion in children. Ear Hear 1992; 13: 442-453.
20. Nozza RJ, Bluestone CD, Kardatzke D, Bachman R: Identification of middle ear effusion by aural acoustic admittance and otoscopy. Ear Hear 1994;15:310-323.
21. Roush J, Bryant K, Mundy M, Zeisel S, Roberts J: Developmental changes in static admittance and tympanometric width in infants and toddlers. J Am Acad Audiol 1995; 6:334-338.
22. De Chicchis AR, Todd NW, Nozza RJ: Developmental changes in aural acoustic admittance measurements. J Am Acad Audiol 2000;11:97-102.
23. Shanks JE, Stelmachowicz PG, Beauchaine KL, Schulte L: Equivalent ear canal volumes in pre- and post-tympanostomy tube insertion. J Speech Hear Res 1992;35:936-941.
24. Morimoto N, Tanaka T, Taiji H, Horikawa R, Naiki Y, Morimoto Y, Kawashiro N: Hearing loss in Turner syndrome. J Pediatr 2006; 149: 697-701.
25. Perkiomaki MR, Kyrkanides S, Niinimaa A, Alvesalo L: The relationship of distinct craniofacial features between Turner syndrome females and their parents. Eur J Orthod 2005; 27: 48-52.
26. Bluestone CD, Klein JO: Otitis media, telectasis, and eustachian tube dysfunction; in Bluestone CD, Stool SE (eds): Pediatric Otolaryngology, ed 2. Philadelphia, Saunders, 1990, pp 332-334.
27. Barrenas M, Landin-Wilhelmsen K, Hanson C: Ear and hearing in relation to genotype and growth in Turner syndrome. Hear Res 2000;144: 21-28.
28. Rao E, Weiss B, Fukami M, Rump A, Niesler B, Mertz A, Muroya K, Binder G, Kirsch S, Winkelmann M, Nordsiek G, Heinrich U, Breuning MH, Ranke MB, Rosenthal A, Ogata T, Rappold GA: Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome. Nat Genet 1997;16:54-63.
29. Clement-Jones M, Schiller S, Rao E, Blaschke RJ, Zuniga A, Zeller R, Robson SC, Binder G, Glass I, Strachan T, Lindsay S, Rappold GA: The short stature homeobox gene SHOX is involved in skeletal abnormalities in Turner syndrome. Hum Mol Genet 2000; 9: 695702.
30. Larsen WJ: Development of the head and neck; in Human Embryology. New York, Churchill Livingstone, 1993, pp 311-374.
31. Ostberg JE, Beckman A, Cadge B, Conway GS: Oestrogen deficiency and growth hormone treatment in childhood are not associated with hearing in adults with Turner syndrome. Horm Res 2004;62:182-186.
32. Hultcrantz M, Sylven L, Borg E: Ear and hearing problems in 44 middle-aged women with Turner's syndrome. Hear Res 1994;76: 127-132.
33. Hamelin CE, Anglin G, Quigley CA, Deal CL: Genomic imprinting in Turner syndrome: effects on response to growth hormone treatment and on risk of sensorineural hearing loss. J Clin Endocrinol Metab 2006; 91:3002-3010.
34. Roush J, Davenport ML, Carlson-Smith C: Earlyonset sensorineural hearing loss in a child with Turner syndrome. J Am Acad Audiol 2000;11:446-453.
35. Fish JH 3rd, Schwentner I, Schmutzhard J, Abraham I, Ciorba A, Martini A, Sergi C, Schrott-Fischer A, Glueckert R: Morphology studies of the human fetal cochlea in Turner syndrome. Ear Hear 2009;30:143-146.
36. Van Erum R, Mulier M, Carels C, Verbeke G, de Zegher F: Craniofacial growth in short children born small for gestational age: effect of growth hormone treatment. J Dent Res 1997;76:1579-1586. (Pubitemid 127748951)
37. Blum WF, Crowe BJ, Quigley CA, Jung H, Cao D, Ross JL, Braun L, Rappold G, SHOX Study Group: Growth hormone is effective in treatment of short stature associated with short stature homeobox-containing gene deficiency: two-year results of a randomized, controlled, multicenter trial. J Clin Endocrinol Metab 2007;92:219-228.
38. Paradise JL, Dollaghan CA, Campbell TF, Feldman HM, Bernard BS, Colborn DK, Rockette HE, Janosky JE, Pitcaim DL, Kurs- Lasky M, Sabo L, Smith CG: Otitis media and tympanostomy tube insertion during the first three years of life: developmental outcomes at the age of four years. Pediatrics 2003;112:265-277.
39. Roberts JE, Rosenfeld RM, Zeisel SA: Otitis media and speech and language: a meta- analysis of prospective studies. Pediatrics 2004;113:e238-e248.
40. Rovet J: Turner syndrome: a review of genetic and hormonal influences on neuropsychological functioning. Child Neuropsychol 2004;10:262-279.